Low prevalence of occult hepatitis B virus infection in chronic haemodialysis and kidney transplant patients.
Marion MucheFlorian van BoemmelSunda RimplerAdrienne StaedtlerStefan BöhmPeter NickelSeema Baid-AgrawalPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
We found nil prevalence of OBI in CHD patients and a very low prevalence (<1%) in KTxR suggesting that routine screening for HBV DNA is not required in CHD population in our region. However, in KTxR, pretransplant screening with HBV DNA should be considered. Testing for HBV DNA in PBMCs does not seem to be of additional value.